Partnerships & Projects

Developing partnerships with a range of institutions - including universities, hospitals, schools, businesses and government - is a key priority and strength of the School.

The Partnerships and Projects team supports strategic partnership projects for OVPH. These include providing operations and project management support for UCLPartners Academic Health Science Centre (AHSC), the Francis Crick Institute, and CASMI.

International partnerships

SLMS has hundreds of partnerships and collaborations around the world, ranging from research collaborations with leading universities to student exchanges and agreements with business and industry. Our international partnerships are supported and managed by the Global Engagement Office, who also maintain a list of current agreements.

Key partnerships

UCLPartners

UCLPartners is an academic health science partnership with over 40 higher education and NHS members. It facilitates the improvement of healthcare through a range of clinical and academic designated roles, as an Academic Health Science Centre (AHSC), Academic Health Science Network (AHSN), an Education Lead Provider and aligned with the NIHR Collaboration for Leadership in Applied Health Research and Care and the NIHR Clinical Research Network North Thames.

UCLPartners is the only academic health science partnership in the country to align all of these NHS and Department of Health designated roles under one umbrella to translate innovation into health and wealth benefits for patients.

The work of the UCLPartners AHSC is facilitated by the Office of the Vice Provost (Health), providing coordination and project management support for the six programmes and three cross-cutting domains:

The Francis Crick Institute

The Francis Crick Institute is an inter-disciplinary medical research institute next to St Pancras railway station near UCL's Bloomsbury campus. Its work will help understand why disease develops and find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease and stroke, infections, and neurodegenerative diseases.

It is a consortium of six of the UK's most successful scientific and academic organisations - the Medical Research Council, Cancer Research UK, the Wellcome Trust, UCL, Imperial College London and King's College London.

Institute of Immunity and Transplantation (IIT)

The IIT will be a world-class centre of excellence dedicated to the study of the human immune system. It will bring together scientists, clinicians, nurses and patients to discover how defects of the immune system lead to disease and to develop new forms of immunotherapy. It will combine the clinical excellence of the Royal Free London’s hospitals and the research excellence of scientists at UCL bringing together teams of more than 200 experts and more than 10,000 patients.

Oriel

Oriel is the joining together and relocation of the UCL Institute of Ophthalmology (IoO) and Moorfields Eye Hospital into a new facility. The new building will be a world class centre co-located with clinical care and researcher, creating a truly collaborative environment. The integration will enhance the IoO’s research productivity and revenue generation, accelerate translation via optimal access to patients, their data and bio-samples and lead to clinical and societal impact.

Zayed Centre for Research into Rare Disease in Children

The Zayed Centre for Research (ZCR) is a world-leading centre of excellence that will enable scientists and clinicians to more accurately diagnose, treat and cure young people with rare diseases.

The ZCR combines the expertise of nearly 500 academics and clinical staff from UCL and GOSH with an outpatient facility that can accommodate over 200 patients and accompanying family members at any one time.
The strategic positioning of the new centre and its proximity to both the UCL Great Ormond Street Institute of Child Health and GOSH is vital for a truly translational and patient-focussed approach to research, building on existing strengths and bringing together teams to embody our bench-to-bedside model.